Adverse drug reaction reports of patients and healthcare professionals—differences in reported information

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|2|152-158

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.2, 2015-02, pp. : 152-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physicians' communication of risks from non‐steroidal anti‐inflammatory drugs and attitude towards providing adverse drug reaction information to patients

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 23, Iss. 6, 2017-12 ,pp. : 1387-1394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recognition and intent of terminal care

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 3, 2015-03 ,pp. : 318-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adverse Drug Reaction Labelling for Atomoxetine, Methylphenidate and Modafinil: Comparison of Product Information for Oral Formulations in Australia, Denmark and the United States

By  

Current Drug Safety, Vol. 8, Iss. 3, 2013-07 ,pp. : 162-168

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Drug Reaction Reporting Related to the Administration of Antibiotics in Hospitalized Pediatric Patients in Greece

By  

Current Drug Safety, Vol. 9, Iss. 1, 2014-03 ,pp. : 49-55

Bentham Science Publishers

Access to resources Recommend Favorite

Brief Communications

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 1, 2015-01 ,pp. : 113-115

John Wiley & Sons Inc

Access to resources Recommend Favorite